Financial News Feed

LAVAL, Québec, May 10, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), today announced that it has settled regarding claims made against the Company by its former chief executive officer (the “Former CEO”) in respect of the termination of his employment...

Read more

No summary available....

Read more

LAVAL, Quebec, Apr 15, 2019 (GLOBE NEWSWIRE via COMTEX) -- More Than 40% of Patients Have Completed Their 6 Month Treatment Plan Top Line Results Remain On…...

Read more

As Biotechnology businesses, Halozyme Therapeutics Inc. (NASDAQ:HALO) and Acasti Pharma Inc. (NASDAQ:ACST), are affected by contrast. This especially applies to their profitability, analyst recommenda...

Read more

Investors may be focusing on technical signals for Acasti Pharma (ACST). Looking at the reading from the 20-day moving average vs price signal, we can see that the signal is showing Sell. This is the ...

Read more

Further validates prior study results demonstrating that the bioavailability of CaPre is significantly better than LOVAZA when taken with a low-fat meal LAVAL, Québec,....

Read more

The Ultimate Oscillator level is currently above 60 on shares of Acasti Pharma (ACST). Active traders may be closely following the indicator to see if overbought conditions are present at current leve...

Read more

Investors may be interested in following the opinion signal on shares of Acasti Pharma (ACST). For the current trading period, we can see that the opinion signal on the stock is 8% Buy. Heading back f...

Read more

Acasti Pharma Inc. (NASDAQ:ACST) and Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) have been rivals in the Biotechnology for quite some time. Below is a review of...

Read more

We are comparing Acasti Pharma Inc. (NASDAQ:ACST) and Arcturus Therapeutics Ltd. (NASDAQ:ARCT) on their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and v...

Read more

We will be comparing the differences between Acasti Pharma Inc. (NASDAQ:ACST) and DBV Technologies S.A. (NASDAQ:DBVT) as far as risk, institutional ownership, analyst recommendations, profitability, d...

Read more

Acasti Pharma Inc. (NASDAQ:ACST) and Axsome Therapeutics Inc. (NASDAQ:AXSM) compete with each other in the Biotechnology sector. We will analyze and compare their analyst recommendations, profitabilit...

Read more

Since Acasti Pharma Inc. (NASDAQ:ACST) and Allakos Inc. (NASDAQ:ALLK) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the analyst recommenda...

Read more

Concert Pharmaceuticals Inc. (NASDAQ:CNCE) and Acasti Pharma Inc. (NASDAQ:ACST) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects ...

Read more

Since Esperion Therapeutics Inc. (NASDAQ:ESPR) and Acasti Pharma Inc. (NASDAQ:ACST) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the prof...

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank